86.31  -3.69 (-4.1%)		10-30 16:00
Open: 89.58 High: 90.23 Volume: 164,836		Pre. Close: 90 Low: 85.565 Market Cap: 808(M)

Short term
Mid term
Targets	6-month :	108.02	1-year :	126.17
Resists	First :	92.48	Second :	108.02
Pivot price	84.43
Supports	First :	84.33	Second :	79.3
MAs	MA(5) :	87.16	MA(20) :	85.41
	MA(100) :	88.16	MA(250) :	76.86
MACD	MACD :	-0.1	Signal :	-0.7
%K %D	K(14,3) :	84.5	D(3) :	82.3
RSI	RSI(14): 50.9
52-week	High :	100	Low :	50.22

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TRNS ] has closed below upper band by 34.4%. Bollinger Bands are 9.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	90.3 - 90.76	90.76 - 91.05
Low:	84.51 - 85.09	85.09 - 85.47
Close:	85.46 - 86.35	86.35 - 86.92

Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.

Sat, 31 Oct 2026
Transcat, Inc. (TRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Thu, 29 Oct 2026
Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive? - Yahoo Finance

Sat, 24 Oct 2026
Precision Trading with Transcat Inc. (TRNS) Risk Zones - Stock Traders Daily

Tue, 20 Oct 2026
Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time - Business Wire

Wed, 16 Sep 2026
Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point (NASDAQ:TRNS) - Seeking Alpha

Mon, 31 Aug 2026
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical - Business Wire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Industrials
Industry: Specialty Business Services
Shares Out	9 (M)
Shares Float	9 (M)
Held by Insiders	2.4 (%)
Held by Institutions	104.8 (%)
Shares Short	469 (K)
Shares Short P.Month	490 (K)

EPS	0.36
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	32.36
Profit Margin	0.9 %
Operating Margin	5.4 %
Return on Assets (ttm)	2.1 %
Return on Equity (ttm)	1.1 %
Qtrly Rev. Growth	21.6 %
Gross Profit (p.s.)	12.09
Sales Per Share	37.22
EBITDA (p.s.)	4.58
Qtrly Earnings Growth	-60 %
Operating Cash Flow	40 (M)
Levered Free Cash Flow	28 (M)

PE Ratio	239.74
PEG Ratio	0
Price to Book value	2.66
Price to Sales	2.31
Price to Cash Flow	20.17

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.